97 related articles for article (PubMed ID: 21247508)
1. Distribution of high and low risk HPV types by cytological status: a population based study from Italy.
Giorgi Rossi P; Chini F; Bisanzi S; Burroni E; Carillo G; Lattanzi A; Angeloni C; Scalisi A; Macis R; Pini MT; Capparucci P; Guasticchi G; Carozzi FM;
Infect Agent Cancer; 2011 Jan; 6():2. PubMed ID: 21247508
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study.
Giorgi Rossi P; Bisanzi S; Paganini I; Di Iasi A; Angeloni C; Scalisi A; Macis R; Pini MT; Chini F; Carozzi FM;
BMC Infect Dis; 2010 Jul; 10():214. PubMed ID: 20646310
[TBL] [Abstract][Full Text] [Related]
3. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.
Riethmuller D; Gay C; Bertrand X; Bettinger D; Schaal JP; Carbillet JP; Lassabe C; Arveux P; Seilles E; Mougin C
Diagn Mol Pathol; 1999 Sep; 8(3):157-64. PubMed ID: 10565688
[TBL] [Abstract][Full Text] [Related]
4. The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women.
Nielsen A; Iftner T; Nørgaard M; Munk C; Junge J; Kjaer SK
Sex Transm Infect; 2012 Dec; 88(8):627-32. PubMed ID: 22773328
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
[TBL] [Abstract][Full Text] [Related]
6. Screening for cervical cancer: new alternatives and research.
Lörincz AT
Salud Publica Mex; 2003; 45 Suppl 3():S376-87. PubMed ID: 14746031
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples.
Huang SL; Chao A; Hsueh S; Chao FY; Huang CC; Yang JE; Lin CY; Yan CC; Chou HH; Huang KG; Huang HJ; Wu TI; Tseng MJ; Qiu JT; Lin CT; Chang TC; Lai CH
J Clin Microbiol; 2006 May; 44(5):1733-9. PubMed ID: 16672400
[TBL] [Abstract][Full Text] [Related]
9. Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.
Liang LA; Einzmann T; Franzen A; Schwarzer K; Schauberger G; Schriefer D; Radde K; Zeissig SR; Ikenberg H; Meijer CJLM; Kirkpatrick CJ; Kölbl H; Blettner M; Klug SJ
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):474-484. PubMed ID: 33187968
[TBL] [Abstract][Full Text] [Related]
10. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus testing and conventional pap smear cytology as optional screening tools of women at different risks for cervical cancer in the countries of the former soviet union.
Syrjänen S; Shabalova IP; Petrovichev N; Kozachenko VP; Zakharova T; Pajanidi J; Podistov JI; Chemeris G; Sozaeva LG; Lipova EV; Tsidaeva I; Ivanchenko OG; Pshepurko AA; Zakharenko S; Nerovjna R; Kljukina LB; Erokhina OA; Branovskaja MF; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Tosi P; Cintorino M; Santopietro R; Syrjänen KJ
J Low Genit Tract Dis; 2002 Apr; 6(2):97-110. PubMed ID: 17051008
[TBL] [Abstract][Full Text] [Related]
12. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
13. Relevance of HPV Screening for Triaging Equivocal Cytology Findings in the Pap II-p, Pap III and Pap IIID Groups - Results of Two Long-Term Studies.
Luyten A; Petry KU
Geburtshilfe Frauenheilkd; 2015 Oct; 75(10):1058-1062. PubMed ID: 26556908
[No Abstract] [Full Text] [Related]
14. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
16. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
17. Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs.
Kantathavorn N; Mahidol C; Sritana N; Sricharunrat T; Phoolcharoen N; Auewarakul C; Teerayathanakul N; Taepisitpong C; Saeloo S; Sornsamdang G; Udomchaiprasertkul W; Krongthong W; Arnamwong A
Infect Agent Cancer; 2015; 10():7. PubMed ID: 25737740
[TBL] [Abstract][Full Text] [Related]
18. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
19. Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum.
Lukic A; Canzio C; Patella A; Giovagnoli M; Cipriani P; Frega A; Moscarini M
Anticancer Res; 2006; 26(6C):4843-9. PubMed ID: 17214350
[TBL] [Abstract][Full Text] [Related]
20. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
